GLP-1 drugs could cut mortality rates in US and UK, Swiss Re says
Swiss Re, a reinsurance company based in Zurich, has released new research suggesting that GLP-1 weight-loss medications could…
Skinny Legend: Ozempic, Body Politics and Unwellness as Aspiration
I. “If there hasn’t been an Ozempic allegation against you by 2025, are you even hot?” I joked…
Leading health organizations release guidance on nutrition support for GLP-1 obesity therapies
Four leading organizations in lifestyle medicine, obesity medicine, and nutrition-the American College of Lifestyle Medicine (ACLM), the American…
Healthcare groups urge FDA to act on compounding regulations after GLP-1 medicine shortages
Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food…